The Pipotiazine Market is positioned for steady expansion as pharmaceutical stakeholders, healthcare providers, and investors increasingly recognize the value of effective antipsychotic treatments. According to The Insight Partners, the Pipotiazine Market is expected to register a CAGR of 5% from 2025 to 2031, underscoring sustained demand for therapeutic solutions in psychiatric care. In...